Maxim Group Keeps Their Buy Rating on Nephros (NEPH)

Retrieved on: 2021-10-09 19:46:19

Tags for this article:

Click the tags to see associated articles and topics

Maxim Group Keeps Their Buy Rating on Nephros (NEPH). View article details on hiswai:

Excerpt

Vendetti covers the Healthcare sector, focusing on stocks such as Applied DNA Sciences, Milestone Scientific, and Dermata Therapeutics.

Article found on: www.analystratings.com